XFOR X4 Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 6, 2026
$2,83
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$2,75minimo 52 sett.
$4,83massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$272M
P/E (TTM)
2.2
EPS (TTM)
$1.27
Ricavi (TTM)
$9M
i tuoi badge
Intervallo 52 sett.
$3–$5
Rating Analisti
STRONG BUY
Prezzo Obiettivo
$12
P/E
2.2
ROE
-113.1%
Margine di Profitto Netto
-1029.4%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
XFOR Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$2.83
Capitalizzazione di Mercato (MRQ)
$272M
P/E (TTM)
2.2
EPS (TTM)
$1.27
Ricavi (TTM)
$9M
ROE (TTM)
-113.1%
Intervallo 52 sett.
$3–$5
XFOR Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 28 Aprile 2025 | 1-for-30 | Inverso |
| 14 Marzo 2019 | 1-for-6 | Inverso |
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$6M2018-12-31 → 2025-12-31
EPS$-1.872020-12-31 → 2025-12-31
Flusso di cassa libero$-86M2018-12-31 → 2025-12-31
Margine netto-1029.4%2018-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | XFOR | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | 2.2media 5 anni ≈-8.9 | ≈-8.9 | · | · | |
| P/S (TTM) | 31.1 | · | 25.4 | Sopravvalutato | |
| P/B (MRQ) | 1.7media 5 anni ≈66.7 | ≈66.7 | 2.9 | Valore equo | |
| Price / FCF (Prezzo / FCF) | -3.0media 5 anni ≈-30.1 | ≈-30.1 | · | · | |
| Price / Cash Flow (Prezzo / Flusso di cassa) | -3.0media 5 anni ≈-30.2 | ≈-30.2 | · | · | |
| Prezzo / Valore contabile tangibile (MRQ) | 1.9media 5 anni ≈58.0 | ≈58.0 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | XFOR | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine Operativo (TTM) | -1003.9% | · | -397.9% | Debole | |
| Margine EBITDA (TTM) | -984.9% | · | -397.9% | Debole | |
| Margine ante imposte (TTM) | -1029.8% | · | -482.4% | Debole | |
| Margine di Profitto Netto (TTM) | -1029.4% | · | -355.9% | Debole | |
| ROA (TTM) | -50.3%media 5 anni ≈-54.3% | ≈-54.3% | -45.0% | Di prim'ordine | |
| ROE (TTM) | -113.1%media 5 anni ≈-123.4% | ≈-123.4% | -68.7% | Debole | |
| ROIC | -46.7%media 5 anni ≈-96.4% | ≈-96.4% | -45.0% | Debole |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | XFOR | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 11.3media 5 anni ≈6.2 | ≈6.2 | 7.8 | Liquidità elevata | |
| Quick Ratio | 8.4media 5 anni ≈5.2 | ≈5.2 | 3.9 | Liquidità elevata |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | XFOR | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 150.0% | · | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | 16.7% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | XFOR | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.0media 5 anni ≈0.0 | ≈0.0 | 0.2 | Debole | |
| Receivables Turnover (Rotazione dei crediti) | 7.9 | · | 6.5 | Di prim'ordine | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$144.4K | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
32.2%
Prossimo report
Nov 03, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 6, 2026 | $-0.13 | $-0.18 | 29.2% |
| 31 Marzo 2026 | $-0.16 | $-0.20 | 21.6% | |
| 31 Dicembre 2025 | $-0.22 | $-0.35 | 37.9% | |
| 30 Settembre 2025 | $-0.69 | $-0.93 | 26.1% | |
| 30 Giugno 2025 | $-3.47 | $-4.42 | 21.6% | |
| 31 Marzo 2025 | $0.04 | $-4.53 | 100.9% | |
| 31 Dicembre 2024 | $-6.00 | $-5.36 | -12.0% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6M | $3M | $0 | $0 | $0 | $3M | $0 | $0 | |
| Cost of Revenue | $6M | $797.0K | $0 | $0 | · | · | · | · | |
| R&D Expense | $73M | $82M | $72M | $61M | $51M | $42M | $30M | $20M | |
| SG&A Expense | $44M | $62M | $36M | $27M | $25M | $21M | $18M | $9M | |
| Operating Expenses | · | $39M | $108M | $88M | $85M | $63M | $52M | $29M | |
| Operating Income | $-87M | $-36M | $-108M | $-88M | $-85M | $-60M | $-52M | $-29M | |
| Interest Expense | · | · | $6M | $4M | $4M | $3M | $2M | $720.0K | |
| Interest Income | $5M | $6M | $5M | $219.0K | $10.0K | $273.0K | $1M | $236.0K | |
| Other Non-op | $-753.0K | $332.0K | $554.0K | $-4M | $426.0K | $905.0K | $517.0K | $0 | |
| Pretax Income | $-79M | $-37M | $-101M | $-94M | $-89M | $-62M | $-53M | $-33M | |
| Income Tax | $41.0K | $310.0K | $78.0K | $28.0K | $17.0K | $148.0K | $0 | $0 | |
| Net Income | $-79M | $-37M | $-101M | $-94M | $-89M | $-62M | $-53M | $-33M | |
| EPS (Basic) | $-1.87 | $-5.59 | $-17.07 | $-1.52 | $-3.99 | $-3.09 | · | · | |
| EPS (Diluted) | $-1.87 | $-5.59 | $-17.07 | $-1.52 | $-3.99 | $-3.09 | · | · | |
| Shares (Basic) | 42,292,818 | 6,702,073 | 5,927,082 | 63,525,845 | 25,748,797 | 20,077,000 | · | · | |
| Shares (Diluted) | 42,292,818 | 6,702,073 | 5,927,082 | 63,525,845 | 25,748,797 | 20,077,000 | · | · | |
| EBITDA | $-86M | $-36M | $-107M | $-87M | $-85M | $-60M | $-52M | $-46M |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $217M | $56M | $99M | $122M | $82M | $79M | $126M | $8M | |
| Receivables | $573.0K | $1M | $0 | · | · | · | $0 | · | |
| Inventory | · | $3M | $0 | · | · | · | · | · | |
| Prepaid Expense | $4M | $6M | $7M | $6M | $5M | $4M | $1M | $1M | |
| Current Assets | $262M | $112M | $122M | $129M | $88M | $83M | $129M | $9M | |
| PP&E (Net) | $182.0K | $776.0K | $745.0K | $1M | $2M | $1M | $403.0K | $241.0K | |
| PP&E (Gross) | $1M | $3M | $2M | $2M | $2M | $2M | $667.0K | $417.0K | |
| Accum. Depreciation | $1M | $2M | $2M | $1M | $724.0K | $274.0K | $264.0K | $176.0K | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $27M | $27M | $0 | |
| Intangibles | $9M | $10M | $0 | · | · | · | · | · | |
| Other Non-current Assets | $692.0K | $2M | $1M | $1M | $2M | $3M | $2M | $364.0K | |
| Total Assets | $290M | $146M | $147M | $156M | $117M | $123M | $161M | $10M | |
| Accounts Payable | $6M | $9M | $9M | $8M | $4M | $3M | $2M | $3M | |
| Accrued Liabilities | $19M | $23M | $13M | $12M | $8M | $8M | $6M | $3M | |
| Current Liabilities | $26M | $33M | $23M | $22M | $14M | $12M | $9M | $8M | |
| Capital Leases | $0 | $1M | $3M | $4M | $5M | $4M | $2M | · | |
| Other Non-current Liabilities | $525.0K | $831.0K | $432.0K | $173.0K | $826.0K | $462.0K | $16.0K | $205.0K | |
| Total Liabilities | $104M | $124M | $96M | $82M | $53M | $50M | $31M | $22M | |
| Long-term Debt | $75M | $75M | $55M | $32M | $32M | $32M | $20M | $10M | |
| Total Debt | · | · | $55M | $34M | $34M | · | $20M | · | |
| Common Stock | $91.0K | $6.0K | $167.0K | $122.0K | $28.0K | $16.0K | $16.0K | $0 | |
| Retained Earnings | $-595M | $-515M | $-478M | $-377M | $-283M | $-194M | $-132M | $-79M | |
| AOCI | $-109.0K | $-122.0K | $-119.0K | $-119.0K | $-119.0K | $-119.0K | $-119.0K | $0 | |
| Stockholders' Equity | $186M | $22M | $51M | $74M | $64M | $73M | $129M | $-77M | |
| Liabilities + Equity | $290M | $146M | $147M | $156M | $117M | $123M | $161M | $10M | |
| Shares Outstanding | 90,906,920 | 5,698,231 | 167,434,595 | 121,667,250 | 28,127,657 | 16,305,731 | 16,128,862 | 351,652 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $796.0K | $419.0K | $513.0K | $499.0K | $351.0K | $103.0K | $103.0K | |
| Stock-based Comp | $4M | $8M | $9M | $5M | $6M | $5M | $2M | $759.0K | |
| Amort. of Intangibles | · | $500.0K | $0 | $0 | · | · | · | · | |
| Restructuring | $7M | $861.0K | · | · | · | · | · | $2M | |
| Other Non-cash | $-12M | $-102M | $-4M | $11M | $11M | $-2M | $3M | $-4M | |
| Operating Cash Flow | $-86M | $-131M | $-97M | $-77M | $-71M | $-59M | $-48M | $-25M | |
| CapEx | $0 | $326.0K | $60.0K | $103.0K | $615.0K | $1M | $174.0K | $0 | |
| Investing Cash Flow | $8M | $67M | $-15M | $-103.0K | $-615.0K | $-1M | $27M | $0 | |
| Net Debt Issued | $0 | $0 | $-2M | $-795.0K | $0 | $0 | $-9M | $-5M | |
| Stock Issued | $239M | $0 | $60M | · | · | · | · | · | |
| Stock Repurchased | · | · | $0 | $0 | $2M | $0 | $0 | · | |
| Net Stock Activity | $239M | · | $0 | $0 | $-2M | · | · | · | |
| Financing Cash Flow | $239M | $20M | $89M | $117M | $74M | $12M | $141M | $7M | |
| Net Change in Cash | $161M | $-44M | $-23M | $40M | $2M | $-47M | $120M | $-19M | |
| Taxes Paid | $338.0K | · | · | · | · | · | · | · | |
| Free Cash Flow | $-86M | $-131M | $-97M | $-77M | $-72M | $-60M | $-48M | $-41M | |
| Levered FCF | · | · | $-102M | $-81M | $-75M | $-63M | · | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1336.7% | -1423.6% | · | · | · | -1995.8% | · | -1311.0% | |
| Net Margin | -1218.5% | -1464.6% | · | · | · | -2071.0% | · | -1229.2% | |
| Pretax Margin | -1217.8% | -1452.5% | · | · | · | -2066.1% | · | -1229.2% | |
| EBITDA Margin | -1317.0% | -1392.5% | · | · | · | -1984.1% | · | -1306.6% | |
| ROA | -36.2% | -25.5% | -66.8% | -68.8% | -73.9% | -43.8% | -61.9% | -73.4% | |
| ROE | -83.2% | -91.6% | -170.5% | -138.1% | -133.3% | -76.5% | -50.7% | 193.4% | |
| ROIC | -46.7% | -165.7% | -101.8% | -81.4% | -86.6% | -82.4% | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.2 | 3.4 | 5.3 | 5.8 | 6.3 | 7.0 | 13.7 | 6.5 | |
| Quick Ratio | 8.4 | 1.7 | 4.3 | 5.5 | 5.8 | 6.6 | 13.4 | 5.7 | |
| Debt / Equity | · | · | 1.1 | 0.5 | 0.5 | · | 0.2 | · | |
| LT Debt / Equity | · | · | 1.1 | 0.4 | 0.5 | · | 0.2 | · | |
| Interest Coverage | · | · | -18.6 | -21.9 | -23.4 | -22.3 | -24.1 | -44.2 |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | |
| Inventory Turnover | · | 0.6 | · | · | · | · | · | · | |
| Receivables Turnover | 7.9 | 4.8 | · | · | · | · | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.05 | $0.13 | $0.31 | $0.61 | $2.29 | $4.46 | $8.01 | $1.48 | |
| Revenue / Share | $0.15 | $0.01 | · | $0.00 | · | · | · | · | |
| Cash Flow / Share | $-2.02 | $-0.65 | $-0.54 | $-1.21 | · | · | · | · | |
| Cash / Share | $2.39 | $0.33 | $0.59 | $1.00 | $2.91 | $4.83 | $7.82 | $2.11 | |
| EPS (TTM) | $-1.87 | $-5.59 | $-17.07 | $-1.52 | $-3.99 | $-3.09 | · | · |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 150.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 16.7% | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6M | $3M | $0 | $0 | $0 | $3M | $0 | $0 | |
| Net Income TTM | $-79M | $-37M | $-101M | $-94M | $-89M | $-62M | $-53M | $-33M | |
| Market Cap | $364M | $3.76B | $4.21B | $3.62B | $1.93B | $3.15B | $5.18B | $6.09B | |
| Enterprise Value | · | · | $4.17B | $3.54B | $1.88B | · | $5.07B | · | |
| P/E | -2.1 | -3.9 | -1.5 | -19.6 | -17.2 | -62.4 | · | · | |
| P/S | 55.9 | 1447.8 | · | · | · | 1048.5 | · | · | |
| P/B | 2.0 | 170.0 | 82.5 | 48.9 | 30.0 | 43.2 | 40.1 | 281.7 | |
| P / Tangible Book | 2.3 | · | 124.9 | 63.9 | 41.1 | 68.8 | · | · | |
| P / Cash Flow | -4.2 | -28.8 | -43.7 | -47.0 | -27.3 | -53.5 | -107.7 | -148.8 | |
| P / FCF | -4.2 | -28.7 | -43.6 | -46.9 | -27.0 | -52.3 | -107.3 | -148.7 | |
| EV / EBITDA | · | · | -38.9 | -40.6 | -22.3 | · | -98.3 | · | |
| EV / FCF | · | · | -43.2 | -45.8 | -26.3 | · | -105.1 | · | |
| Earnings Yield | -46.8% | -25.4% | -67.8% | -5.1% | -5.8% | -1.6% | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $2M | $2M | $2M | $900.0K | $2M | $560.0K | $563.0K | · | $0 | $0 | $0 | · | · | · | |
| Cost of Revenue | $2M | $598.0K | $364.0K | $351.0K | $326.0K | $5M | $302.0K | $227.0K | $268.0K | $0 | $0 | $0 | $0 | · | · | · | |
| R&D Expense | $15M | $15M | $19M | $17M | $18M | $19M | $22M | $19M | $21M | $20M | $15M | $19M | $16M | $22M | $19M | $14M | |
| SG&A Expense | $9M | $7M | $7M | $12M | $10M | $15M | $15M | $16M | $13M | $17M | $10M | $8M | $10M | $7M | $7M | $6M | |
| Operating Expenses | · | · | · | · | · | · | · | · | · | $37M | · | $27M | $26M | $29M | $26M | $20M | |
| Operating Income | $-16M | $-20M | $-24M | $-28M | $-26M | $-9M | $-36M | $-34M | $71M | $-37M | $-25M | $-27M | $-26M | $-29M | $-26M | $-20M | |
| Interest Expense | · | · | · | · | · | · | · | $2M | $2M | $2M | · | $2M | $1M | $1M | · | $1M | |
| Interest Income | $2M | $2M | $2M | $901.0K | $665.0K | $1M | $1M | $2M | $2M | $1M | $1M | $1M | $914.0K | $835.0K | $198.0K | $14.0K | |
| Other Non-op | $-107.0K | $14.0K | $-7.0K | $-304.0K | $-547.0K | $105.0K | $700.0K | $226.0K | $144.0K | $105.0K | $212.0K | $17.0K | $202.0K | $123.0K | $-4M | $-441.0K | |
| Pretax Income | $-16M | $-20M | $-24M | $-30M | $-26M | $316.0K | $-40M | $-37M | $91M | $-52M | $-19M | $-2M | $-56M | $-24M | $-29M | $-22M | |
| Income Tax | $2.0K | $0 | $0 | $-30.0K | $37.0K | $34.0K | $258.0K | $15.0K | $18.0K | $19.0K | $33.0K | $26.0K | $15.0K | $4.0K | $14.0K | $-13.0K | |
| Net Income | $-16M | $-20M | $-24M | $-30M | $-26M | $282.0K | $-40M | $-37M | $91M | $-52M | $-19M | $-2M | $-56M | $-24M | $-29M | $-22M | |
| EPS (Basic) | $-0.13 | $-0.16 | $2.25 | $-0.69 | $-3.47 | $0.04 | $-5.93 | $-5.48 | $13.59 | $-7.77 | $-16.57 | $-0.01 | $-0.33 | $-0.16 | $0.06 | $-0.26 | |
| EPS (Diluted) | $-0.13 | $-0.16 | $2.25 | $-0.69 | $-3.47 | $0.04 | $-5.91 | $-5.48 | $13.57 | $-7.77 | $-16.57 | $-0.01 | $-0.33 | $-0.16 | $0.06 | $-0.26 | |
| Shares (Basic) | 126,344,020 | 126,288,723 | · | 43,272,773 | 7,412,990 | 6,840,035 | · | 6,695,509 | 6,681,349 | 6,666,386 | · | 196,987,827 | 168,737,764 | 145,967,476 | · | 83,211,000 | |
| Shares (Diluted) | 126,344,020 | 126,288,723 | · | 43,272,773 | 7,412,990 | 6,869,084 | · | 6,695,509 | 6,693,376 | 6,666,386 | · | 196,987,827 | 168,737,764 | 145,967,476 | · | 83,211,000 | |
| EBITDA | $-16M | $-20M | · | $-28M | $-26M | $-9M | · | $-34M | $71M | $-37M | · | $-27M | $-26M | $-29M | · | $-20M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $195M | $217M | $217M | $70M | $39M | $40M | $56M | $97M | $147M | $60M | · | $132M | $136M | $93M | $122M | $80M | |
| Receivables | $2M | $1M | $573.0K | $891.0K | $1M | $509.0K | $1M | $0 | $0 | · | $0 | · | · | · | · | · | |
| Prepaid Expense | $3M | $3M | $4M | $5M | $5M | $4M | $6M | $4M | $5M | $6M | · | $6M | $6M | $4M | · | $5M | |
| Current Assets | $219M | $242M | $262M | $133M | $73M | $96M | $112M | $143M | $175M | $87M | · | $148M | $148M | $98M | · | $86M | |
| PP&E (Net) | $111.0K | $146.0K | $182.0K | $218.0K | $254.0K | $487.0K | $776.0K | $820.0K | $808.0K | $742.0K | · | $772.0K | $868.0K | $986.0K | · | $1M | |
| PP&E (Gross) | $1M | $1M | $1M | · | $1M | $3M | $3M | $3M | $3M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Accum. Depreciation | $1M | $1M | $1M | · | $1M | $2M | $2M | $2M | $2M | $2M | · | $2M | $1M | $1M | · | $1M | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | |
| Intangibles | $13M | $9M | $9M | $9M | $10M | $10M | $10M | $10M | $10M | · | · | · | · | · | · | · | |
| Other Non-current Assets | $3M | $704.0K | $692.0K | $2M | $2M | $3M | $2M | $2M | $2M | $1M | · | $1M | $1M | $1M | · | $2M | |
| Total Assets | $253M | $270M | $290M | $164M | $105M | $130M | $146M | $178M | $211M | $112M | · | $173M | $173M | $124M | · | $113M | |
| Accounts Payable | $4M | $5M | $6M | $5M | $8M | $11M | $9M | $9M | $8M | $9M | · | $8M | $5M | $6M | · | $4M | |
| Accrued Liabilities | $14M | $17M | $19M | $17M | $13M | $13M | $23M | $19M | $20M | $13M | · | $16M | $15M | $12M | · | $9M | |
| Current Liabilities | $19M | $24M | $26M | $24M | $23M | $26M | $33M | $29M | $29M | $24M | · | $25M | $22M | $19M | · | $29M | |
| Capital Leases | · | · | $0 | $95.0K | $815.0K | $1M | $1M | $2M | $2M | $2M | · | $3M | $3M | $3M | · | $4M | |
| Other Non-current Liabilities | $523.0K | $526.0K | $525.0K | $525.0K | $535.0K | $567.0K | $831.0K | $1M | $979.0K | $1M | · | $1M | $1M | $350.0K | · | $312.0K | |
| Total Liabilities | $98M | $102M | $104M | $102M | $101M | $107M | $124M | $119M | $116M | $111M | · | $106M | $106M | $73M | · | $52M | |
| Long-term Debt | $75M | $75M | $75M | $75M | $75M | $75M | $75M | $75M | $75M | $55M | · | $55M | $32M | $32M | · | $32M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $15M | |
| Common Stock | $96.0K | $94.0K | $91.0K | $25.0K | $8.0K | $6.0K | $6.0K | $168.0K | $168.0K | $168.0K | · | $165.0K | $164.0K | $122.0K | · | $69.0K | |
| Retained Earnings | $-631M | $-615M | $-595M | $-571M | $-541M | $-515M | $-515M | $-476M | $-439M | $-530M | · | $-459M | $-456M | $-401M | · | $-348M | |
| AOCI | $-123.0K | $-122.0K | $-109.0K | $-118.0K | $-138.0K | $-128.0K | $-122.0K | $-114.0K | $-159.0K | $-155.0K | · | $-119.0K | $-119.0K | $-119.0K | · | $-119.0K | |
| Stockholders' Equity | $155M | $168M | $186M | $62M | $4M | $23M | $22M | $60M | $94M | $1M | $51M | $68M | $68M | $52M | $74M | $62M | |
| Liabilities + Equity | $253M | $270M | $290M | $164M | $105M | $130M | $146M | $178M | $211M | $112M | · | $173M | $173M | $124M | · | $113M | |
| Shares Outstanding | 96,114,534 | 94,319,696 | 90,906,920 | 25,146,411 | 7,959,947 | 5,788,745 | 5,698,231 | 168,511,264 | 168,196,180 | 167,937,781 | · | 164,705,712 | 164,418,011 | 122,207,488 | · | 68,734,553 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $997.0K | $223.0K | $223.0K | $223.0K | $355.0K | $476.0K | $273.0K | $267.0K | $194.0K | $62.0K | $62.0K | $104.0K | $126.0K | $127.0K | $124.0K | $124.0K | |
| Stock-based Comp | $3M | $2M | $2M | $760.0K | $748.0K | $519.0K | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $1M | $1M | |
| Amort. of Intangibles | · | · | · | $200.0K | · | · | · | $200.0K | $100.0K | · | · | · | · | · | · | · | |
| Restructuring | $198.0K | $37.0K | $-196.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-2M | · | · | · | $-14M | · | · | · | $16M | · | · | · | $-4M | · | · | |
| Operating Cash Flow | $-21M | $-20M | $-16M | $-28M | $-30M | $-12M | $-33M | $-34M | $-64M | $-34M | $47M | $-69M | $-48M | $-27M | $-19M | $-19M | |
| CapEx | · | · | $0 | $0 | $0 | $0 | $41.0K | $92.0K | $134.0K | $59.0K | $35.0K | $8.0K | $8.0K | $9.0K | $34.0K | $9.0K | |
| Investing Cash Flow | $-1M | $19M | $17M | $-29M | $23M | $-3M | $-9M | $-16M | $97M | $-5M | $-5M | $-5M | $-5M | $-9.0K | $-34.0K | $-9.0K | |
| Stock Issued | · | · | $146M | $87M | · | · | $0 | $-159.0K | · | · | $51M | $2.0K | · | · | · | $0 | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | $443.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $-443.0K | · | · | |
| Financing Cash Flow | $75.0K | $2.0K | $146M | $87M | $6M | $0 | $135.0K | $0 | $20M | $0 | $97.0K | $21M | $69M | $-2M | $61M | $52M | |
| Net Change in Cash | $-22M | $-365.0K | $147M | $30M | $-1M | $-15M | $-42M | $-50M | $87M | $-39M | $-32M | $-5M | $43M | $-29M | $42M | $32M | |
| Free Cash Flow | · | · | · | · | · | $-12M | · | · | · | $-34M | · | · | · | $-27M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-36M | · | · | · | $-28M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -683.0% | -812.2% | · | -1756.6% | -1504.1% | -1049.2% | · | -6160.7% | 12629.3% | · | · | · | · | · | · | · | |
| Net Margin | -673.2% | -809.6% | · | -1903.9% | -1476.0% | 31.3% | · | -6552.9% | 16133.8% | · | · | · | · | · | · | · | |
| Pretax Margin | -673.1% | -809.6% | · | -1905.8% | -1473.8% | 35.1% | · | -6550.2% | 16136.9% | · | · | · | · | · | · | · | |
| EBITDA Margin | -683.0% | -803.3% | · | -1756.6% | -1504.1% | -996.3% | · | -6160.7% | 12629.3% | · | · | · | · | · | · | · | |
| ROA | -9.0% | -10.1% | · | -17.4% | -16.3% | 0.23% | · | -20.9% | 62.3% | -48.9% | · | -1.3% | · | · | · | -18.5% | |
| ROE | -20.3% | -21.1% | · | -49.2% | -52.3% | 2.4% | · | -57.7% | 145.9% | -204.0% | · | -3.4% | · | · | · | -33.1% | |
| ROIC | -10.5% | -12.0% | · | -44.6% | -661.5% | -36.7% | · | -57.9% | 75.3% | -3600.7% | · | -40.7% | · | · | · | -26.3% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.3 | 10.2 | · | 5.6 | 3.2 | 3.7 | · | 4.9 | 6.1 | 3.7 | · | 5.8 | · | · | · | 3.0 | |
| Quick Ratio | 10.2 | 9.2 | · | 3.0 | 1.8 | 1.6 | · | 3.3 | 5.1 | 2.6 | · | 5.2 | · | · | · | 2.8 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | · | · | 0.2 | |
| Interest Coverage | · | · | · | · | · | · | · | -14.3 | 32.7 | -19.9 | · | -16.7 | -22.5 | -26.4 | · | -19.8 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.5 | 3.1 | · | 3.5 | 3.0 | 0.5 | · | · | · | · | · | · | · | · | · | · |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.62 | $1.79 | · | $2.45 | $0.50 | $3.96 | · | $0.35 | $0.56 | $0.01 | · | $0.41 | · | · | · | $0.90 | |
| Revenue / Share | $0.02 | $0.02 | · | $0.04 | $0.24 | $0.13 | · | $0.00 | $0.00 | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.16 | · | · | · | $-1.80 | · | · | $-0.32 | $-0.17 | · | $-0.35 | $-0.28 | $-0.18 | · | · | |
| Cash / Share | $2.03 | $2.30 | · | $2.77 | $4.93 | $6.95 | · | $0.58 | $0.88 | $0.36 | · | $0.80 | · | · | · | $1.16 | |
| EPS (TTM) | $1.27 | $-2.07 | · | $-10.03 | $-14.82 | $2.22 | · | $-16.25 | $-10.78 | $-24.68 | · | $-0.44 | $-0.69 | $-0.96 | · | $-2.86 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9M | $8M | · | $6M | $5M | $4M | · | · | · | · | · | · | · | $0 | · | $0 | |
| Net Income TTM | $-90M | $-100M | · | $-95M | $-102M | $15M | · | $-17M | $18M | $-129M | · | $-111M | $-130M | $-96M | · | $-95M | |
| Market Cap | $449M | $390M | · | $86M | $15M | $41M | · | $3.38B | $2.93B | $7.00B | · | $5.39B | · | · | · | $3.53B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $5.25B | · | · | · | $3.46B | |
| P/E | 3.7 | -2.0 | · | -0.3 | -0.1 | 3.2 | · | -1.2 | -1.6 | -1.7 | · | -74.3 | -84.3 | -27.2 | · | -17.9 | |
| P/S | 51.3 | 48.4 | · | 15.2 | 3.2 | 11.6 | · | · | · | · | · | · | · | · | · | · | |
| P/B | 2.9 | 2.3 | · | 1.4 | 3.8 | 1.8 | · | 56.7 | 31.0 | 6759.7 | · | 79.7 | · | · | · | 57.0 | |
| P / Tangible Book | 3.6 | 2.7 | · | 2.5 | · | · | · | 105.4 | 43.9 | · | · | 107.2 | · | · | · | 79.2 | |
| P / Cash Flow | · | -19.9 | · | · | · | -3.3 | · | · | -45.8 | -208.4 | · | -78.3 | · | · | · | · | |
| Earnings Yield | 27.2% | -50.1% | · | -293.3% | -780.0% | 31.4% | · | -81.0% | -62.0% | -59.2% | · | -1.4% | -1.2% | -3.7% | · | -5.6% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $6M | $3M | $0 | $0 | $0 |
| Margine Operativo % | -1336.7% | -1423.6% | · | · | · |
| Utile netto | $-79M | $-37M | $-101M | $-94M | $-89M |
| EPS Diluito | $-1.87 | $-5.59 | $-17.07 | $-1.52 | $-3.99 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | · | · | 1.1 | 0.5 | 0.5 |
| Rapporto corrente | 10.2 | 3.4 | 5.3 | 5.8 | 6.3 |
| Quick Ratio | 8.4 | 1.7 | 4.3 | 5.5 | 5.8 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-86M | $-131M | $-97M | $-77M | $-72M |
Proprietari istituzionali (13F) 93 filer · $463.3M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
93
Valore detenuto
$463.3M
Nuove posizioni
36
Posizioni chiuse
26
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 36 (+18 vs trimestre precedente) | 26 (+17 vs trimestre precedente) | 23 (+1 vs trimestre precedente) | 13 (-8 vs trimestre precedente) | +8.7M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| MORGAN STANLEY | $44.184.173 | 9.461.279 | 9,54% | Azioni |
| FMR LLC | $38.862.138 | 8.321.657 | 8,39% | Azioni |
| Bain Capital Life Sciences Investors, LLC | $37.208.011 | 7.967.454 | 8,03% | Azioni |
| PERCEPTIVE ADVISORS LLC | $37.049.403 | 7.933.491 | 8,00% | Azioni |
| Saturn V Capital Management LP | $32.565.512 | 6.973.343 | 7,03% | Azioni |
| Empery Asset Management, LP | $32.365.860 | 6.930.591 | 6,99% | Azioni |
| Deep Track Capital, LP | $27.453.795 | 5.878.757 | 5,93% | Azioni |
| BlackRock, Inc. | $25.941.411 | 5.554.906 | 5,60% | Azioni |
| Kalehua Capital Management LLC | $17.385.663 | 3.722.840 | 3,75% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $17.353.062 | 3.715.859 | 3,75% | Azioni |
| Rosalind Advisors, Inc. | $15.012.957 | 3.214.766 | 3,24% | Azioni |
| VANGUARD GROUP INC | $13.694.648 | 3.423.662 | 2,96% | Azioni |
| BRAIDWELL LP | $13.649.261 | 2.922.754 | 2,95% | Azioni |
| Blackstone Inc. | $12.524.576 | 2.681.922 | 2,70% | Azioni |
| Trails Edge Capital Partners, LP | $12.008.803 | 2.571.478 | 2,59% | Azioni |
| Nantahala Capital Management, LLC | $11.439.016 | 2.449.468 | 2,47% | Azioni |
| BVF INC/IL | $10.431.575 | 2.233.742 | 2,25% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $9.800.562 | 2.098.047 | 2,12% | Azioni |
| Venrock Adviser, LLC | $9.032.962 | 1.934.253 | 1,95% | Azioni |
| SAMSARA BIOCAPITAL, LLC | $6.517.391 | 1.395.587 | 1,41% | Azioni |
| STATE STREET CORP | $6.052.399 | 1.296.017 | 1,31% | Azioni |
| Woodline Partners LP | $4.675.114 | 1.001.095 | 1,01% | Azioni |
| GOLDMAN SACHS GROUP INC | $4.280.223 | 916.536 | 0,92% | Azioni |
| NORTHERN TRUST CORP | $3.048.805 | 652.849 | 0,66% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $2.671.417 | 572.038 | 0,58% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.531.738 | 542.128 | 0,55% | Azioni |
| Verdad Advisers, LP | $1.644.274 | 352.093 | 0,35% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.229.443 | 263.264 | 0,27% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.168.901 | 250.300 | 0,25% | Opzione Call |
| Caption Management, LLC | $1.167.500 | 250.000 | 0,25% | Opzione Call |
| Stonepine Capital Management, LLC | $1.050.699 | 224.989 | 0,23% | Azioni |
| Bank of New York Mellon Corp | $916.908 | 196.340 | 0,20% | Azioni |
| Affinity Asset Advisors, LLC | $677.150 | 145.000 | 0,15% | Azioni |
| Nuveen, LLC | $501.507 | 107.389 | 0,11% | Azioni |
| Invesco Ltd. | $451.926 | 96.772 | 0,10% | Azioni |
| ALPS ADVISORS INC | $447.040 | 95.726 | 0,10% | Azioni |
| RHUMBLINE ADVISERS | $444.022 | 95.081 | 0,10% | Azioni |
| Susquehanna Portfolio Strategies, LLC | $407.607 | 87.282 | 0,09% | Azioni |
| DEUTSCHE BANK AG\ | $368.393 | 78.885 | 0,08% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $349.293 | 74.795 | 0,08% | Azioni |
| CITIGROUP INC | $327.423 | 70.112 | 0,07% | Azioni |
| WELLS FARGO & COMPANY/MN | $316.215 | 67.712 | 0,07% | Azioni |
| Palumbo Wealth Management LLC | $313.432 | 67.116 | 0,07% | Azioni |
| Squarepoint Ops LLC | $313.254 | 67.078 | 0,07% | Azioni |
| UBS Group AG | $271.060 | 58.043 | 0,06% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $241.906 | 51.800 | 0,05% | Azioni |
| MetLife Investment Management, LLC | $224.015 | 47.969 | 0,05% | Azioni |
| BANK OF AMERICA CORP /DE/ | $218.841 | 46.861 | 0,05% | Azioni |
| Point72 Asset Management, L.P. | $191.806 | 41.072 | 0,04% | Azioni |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $173.131 | 37.073 | 0,04% | Azioni |
Attivisti e proprietari del 5%+ 10 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Growth Equity Opportunities 18 VGE, LLC, NEA 18 Venture Growth Equity, L.P., NEA Partners 18 VGE, L.P., NEA 18 VGE GP, LLC, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Edward T. Mathers, Scott D. Sandell, Paul Walker, Rick Yang ×5 depositi | 29 Ottobre 2025 | 6,20% | Modifica | Investimento passivo | SEC |
| Coastlands Capital LP, Coastlands Capital Partners LP, Coastlands Capital GP LLC, Coastlands Capital LLC, Matthew D. Perry | 18 Agosto 2025 | 9,99% | Deposito iniziale | · | SEC |
| Bain Capital Life Sciences Fund, L.P., Bain Capital Life Sciences Fund II, L.P., BCIP Life Sciences Associates, LP, BCLS II Investco, LP, BCLS I Investco, LP | 13 Agosto 2025 | 9,99% | Deposito iniziale | · | SEC |
| Polaris Venture Partners V, L.P. (“PVP V”), Polaris Venture Partners Entrepreneurs’ Fund V, L.P. (“PVPE V”), Polaris Venture Partners Founders’ Fund V, L.P. (“PVPFF V”), Polaris Venture Partners Special Founders’ Fund V, L.P. (“PVPSFF V”), Polaris Venture Management Co. V, L.L.C. (“PVM V”), Jonathan A. Flint, Terrance G. McGuire ×2 depositi | 17 Luglio 2019 | · | Deposito iniziale | · | SEC |
| 28 Maggio 2019 | · | Deposito iniziale | · | SEC | |
| Paula Ragan, Ph.D. ×2 depositi | 26 Aprile 2019 | · | Deposito iniziale | M&A / vendita | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP IV LLC ×3 depositi | 19 Marzo 2019 | · | Deposito iniziale | · | SEC |
| X4 Pharmaceuticals, Inc. | 06 Dicembre 2018 | · | Deposito iniziale | M&A / vendita | SEC |
| SVLSF V, LLC, SV Life Sciences Fund V, L.P., SV Life Sciences Fund V Strategic Partners, L.P., SV Life Sciences Fund V (GP), L.P., SVLSF VI, LLC, SV Life Sciences Fund VI, LP., SV Life Sciences Fund VI Strategic Partners, L.P., SV Life Sciences Fund VI (GP), L.P. | 14 Febbraio 2018 | · | Deposito iniziale | Investimento passivo | SEC |
| New Enterprise Associates 16, L.P., NEA Partners 16, L.P., NEA 16 GP, LLC, Peter J. Barris, Forest Baskett, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Joshua Makower, David M. Mott, Chetan Puttagunta, Jon M. Sakoda, Scott D. Sandell, Peter W. Sonsini, Ravi Viswanathan | 29 Novembre 2017 | · | Deposito iniziale | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 39 insider · 17 dirigenti · 21 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Paula Ragan | President and CEO | 12 Febbraio 2025 A | 3.337.386 | 0 | 0 | $0 |
| Michael Gray | President, CEO and CFO | 27 Novembre 2018 A | 250.000 | 0 | 0 | $0 |
| David Kirske | Chief Financial Officer | 30 Giugno 2026 S | 167.750 | 0 | 2 | $-109.156 |
| Adam S. Mostafa | Chief Financial Officer | 12 Febbraio 2025 A | 850.000 | 0 | 0 | $0 |
| John Volpone | President | 12 Agosto 2026 S | 265.305 | 0 | 1 | $-109.117 |
| Mary Dibiase | Chief Operating Officer | 12 Febbraio 2025 A | 1.140.980 | 0 | 0 | $0 |
| Adam R Craig | Executive Chairman | 12 Agosto 2026 S | 328.651 | 0 | 1 | $-210.616 |
| Natasha Fay Thoren | Chief Legal Officer | 20 Maggio 2025 A | 9.462 | 0 | 0 | $0 |
| Mark Baldry | Chief Commercial Officer | 16 Maggio 2025 A | 25.337 | 0 | 0 | $0 |
| Christophe Arbet-Engels | Chief Medical Officer | 12 Febbraio 2025 A | 864.207 | 0 | 0 | $0 |
| Arthur Taveras | Chief Scientific Officer | 07 Ottobre 2024 S | 388.026 | 0 | 0 | $0 |
| Derek M Meisner | Chief Legal Officer | 17 Agosto 2022 S | 145.155 | 0 | 0 | $0 |
| Diego Cadavid | Chief Medical Officer | 01 Marzo 2022 A | 104.107 | 0 | 0 | $0 |
| Renato Skerlj | Chief Scientific Officer | 09 Settembre 2020 S | 42.076 | 0 | 0 | $0 |
| Lynne E Kelley | Chief Medical Officer | 24 Aprile 2019 A | · | 0 | 0 | $0 |
| Eszter Nagy | Chief Scientific Officer | 07 Marzo 2018 A | · | 0 | 0 | $0 |
| David Mantus | Chief Development Officer | 07 Marzo 2018 A | · | 0 | 0 | $0 |
| Kelly Gold | Direttore | 01 Luglio 2026 A | · | 0 | 0 | $0 |
| Francoise De Craecker | Direttore | 01 Gennaio 2026 A | 4.722 | 0 | 0 | $0 |
| Murray Stewart | Direttore | 01 Gennaio 2026 A | 7.883 | 0 | 0 | $0 |
| Gary Bridger | Direttore | 01 Gennaio 2026 A | 4.722 | 0 | 0 | $0 |
| Michael S Wyzga | Direttore | 01 Gennaio 2026 A | 5.555 | 0 | 0 | $0 |
| Keith Woods | Direttore | 09 Giugno 2025 A | 6.000 | 0 | 0 | $0 |
| William Aliski | Direttore | 10 Giugno 2024 A | 96.667 | 0 | 0 | $0 |
| Alison Frances Lawton | Direttore | 10 Giugno 2024 A | 96.667 | 0 | 0 | $0 |
| David W J Mcgirr | Direttore | 10 Giugno 2024 A | 96.667 | 0 | 0 | $0 |
| Rene Russo | Direttore | 02 Giugno 2021 A | · | 0 | 0 | $0 |
| Isaac Blech | Direttore | 13 Marzo 2019 A | · | 0 | 0 | $0 |
| Tillman U. Gerngross | Direttore | 05 Giugno 2018 A | 392.821 | 0 | 0 | $0 |
| Claudio Nessi | Direttore | 05 Giugno 2018 A | 867.639 | 0 | 0 | $0 |
| Amy Schulman | Direttore | 05 Giugno 2018 A | · | 0 | 0 | $0 |
| William D Clark | Direttore | 05 Giugno 2018 A | · | 0 | 0 | $0 |
| GORDON CARL L | Direttore | 05 Giugno 2018 A | 1.868.966 | 0 | 0 | $0 |
| Terrance McGuire | Direttore | 05 Giugno 2018 A | 18.031 | 0 | 0 | $0 |
| Michael Jay Ross | Direttore | 15 Novembre 2017 A | 1.868.961 | 0 | 0 | $0 |
| Anna-Maria & Stephen Kellen Foundation, Inc. | Proprietario del 10% | 20 Novembre 2017 C | 124.381 | 0 | 0 | $0 |
| Bill & Melinda Gates Foundation | Proprietario del 10% | 20 Novembre 2017 C | 722.179 | 0 | 0 | $0 |
| Alexandria Venture Investments, LLC | Proprietario del 10% | 15 Novembre 2017 C | 225.680 | 0 | 0 | $0 |
| Anthony Chris Stevens | · | 07 Marzo 2018 A | · | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 11 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,37% | 29.512 SH | 01 Ottobre 2026 | Giornaliero |
| IWC · iShares Trust | 0,06% | 273.306 SH | 11 Settembre 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 70.293 SH | 19 Agosto 2026 | Giornaliero |
| RSSL · Global X Funds | 0,01% | 38.483 NS | 31 Luglio 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 464.950 SH | 19 Agosto 2026 | Giornaliero |
| IWM · iShares Trust | 0,01% | 2.014.836 SH | 11 Settembre 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 49.598 SH | 30 Settembre 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1.031.672 SH | 19 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.599.387 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.885 SH | 19 Agosto 2026 | Giornaliero |
| IWN · iShares Trust | · | 753.604 SH | 11 Settembre 2026 | Giornaliero |
XFOR Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 11 analisti
COMPRA
Target mediano
$12.00
+324,0%
5 45,5%
Acquisto forte
5 45,5%
Compra
1 9,1%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
5 analisti · 2026-09-29Target medio $11.60 +309,9%
← Sotto tutti i target
Prezzo attuale $2.83
Basso$10.00
Media$11.60
Alto$13.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| XFOR | $364M | -2.1 | 150.0% | -1218.5% | -83.2% | · |
| RZLT | $501M | -6.9 | · | · | -67.8% | · |
| KYTX | $568M | -2.6 | · | · | -77.4% | · |
| IRD | $140M | -2.5 | 29.1% | -349.3% | -302.2% | · |
| AGEN | $111M | · | 10.4% | -2.7% | 1.0% | · |
| ENTA | $256M | -3.1 | -3.4% | -125.4% | -103.5% | · |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | · |
| INDP | $6M | -0.1 | · | · | -2820.8% | · |
| CCCC | $185M | -1.5 | 1.0% | -292.1% | -48.8% | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 6, 2026